Results 151 to 160 of about 69,762 (263)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

A Novel Artificial Vitreous Substitute - Foldable Capsular Vitreous Body

open access: yes, 2012
The natural vitreous is a transparent, gelatinoid structure occupying four-fifths of the volume of the eye. It has a thin, membrane-like structure corresponding to the vitreous cortex that extends from the ora serrata to the posterior pole.1 It is somewhat spherical but slightly flattened meridionally, and it has a cup-shaped depression in its anterior
openaire   +3 more sources

A Comparative Analysis of Deep Convolutional Networks for Automated Diagnosis of Retinal Detachment in Dogs

open access: yesVeterinary Ophthalmology, Volume 29, Issue 3, May 2026.
ABSTRACT Objective To compare ImageNet‐pretrained deep convolutional neural networks for automated detection of retinal detachment (RD) in canine fundus photographs. Animals Studied Archived fundus images from 275 dogs. Procedures In this multicenter retrospective study, 2000 color fundus photographs (793 RD; 1207 normal) acquired between 2020 and 2025
Sıtkıcan Okur   +7 more
wiley   +1 more source

Functional Persistent Luminescent Thin Films and Glasses: Materials, Processing, and Future Challenges

open access: yesAdvanced Optical Materials, Volume 14, Issue 16, 24 April 2026.
Beyond conventional powders, persistent luminescent thin films and glass‐based composites offer transformative potential for transparent, stable photonic devices. This work evaluates diverse processing routes and structure‐property correlations essential for achieving optical transparency and environmental stability.
Luidgi Giordano   +10 more
wiley   +1 more source

Oral Celastrol Nanomedicine Targeting Intestinal Antigen‐Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut‐Retina Axis

open access: yesAdvanced Science, Volume 13, Issue 20, 9 April 2026.
Oral nanoCEL exhibits effective intestinal targeting of antigen‐presenting cells and restores the Th17/Treg balance in lymph nodes and spleen, ultimately protecting the blood‐retinal barrier by inhibiting peripheral immune cell infiltration and suppressing retinal glial cell activation.
Jinrun Chen   +13 more
wiley   +1 more source

Vitreous body

open access: yes, 2018
Clinton Nash   +2 more
openaire   +1 more source

Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review

open access: yesClinical Anatomy, Volume 39, Issue 3, Page 346-367, April 2026.
ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley   +1 more source

Brain Involvement in Leishmaniasis

open access: yesCell Biochemistry and Function, Volume 44, Issue 4, April 2026.
ABSTRACT Leishmaniasis is a neglected tropical disease caused by infection with the protozoan parasite Leishmania and it is a significant global health problem. The disease has a wide clinical spectrum, from tegumentary leishmaniasis (TL) that encompasses cutaneous (CL), mucosal (ML) and cutaneous‐diffuse (CDL) forms, to the potentially fatal systemic ...
Camila S. Freitas   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy